Synovis Life Technologies Inc. (NASDAQ:SYNO) may not have generated many headlines this year (which is not necessarily a bad thing), but the St. Paul company has quietly produced a rather impressive annual performance, especially compared to what remains of Minnesota's shrinking, publicly traded medical device sector.
Ernie Andberg has a little more free time on his hands these days. The long-time “emerging medical device companies” equity analyst for Feltl & Co. in Minneapolis has not seen a lot of companies emerging lately. In fact, they’ve been disappearing all together. Case in point: Medtronic Inc.’s (NYSE: MDT) deal last week to acquire […]
Healthcare is drowning in chaos—from scattered data to burnout-inducing tasks. Discover how smarter workflows and real-time insights can rescue care teams and transform patient outcomes.